In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs

Tropical Medicine and International Health

Volumn 7, Issue 3, 2002, Pages 265-270

  Pradines, B ^a   Tall, A ^b   Rogier, C ^a   Spiegel, A ^b   Mosnier, J ^a   Marrama, L ^b   Fusai, T ^a   Millet, P ^c   Panconi, E ^d   Trape, J F ^e   Parzy, D ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

Drug resistance; Ferrochloroquine; In vitro susceptibility; Malaria; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; ATOVAQUONE; CHLOROQUINE; CYCLOGUANIL; FERROCHLOROQUINE; HALOFANTRINE; MEFLOQUINE; PYRIMETHAMINE; QUININE; UNCLASSIFIED DRUG;

DISEASE CONTROL; DRUG RESISTANCE; MALARIA; PERFORMANCE ASSESSMENT;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS RESISTANCE; DRUG ACTIVITY; DRUG SENSITIVITY; IC 50; IN VITRO STUDY; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM;

SENEGAL;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036207647     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2002.00848.x     Document Type: Article

References (36)

1. Failure of chloroquine and proguanil prophylaxis in travellers to Kenya
2. Molecular epidemiology of malaria in Yaoude, Cameroon. V. Analysis of the omega repetitive region of the Plasmodium falciparum CG2 gene and chloroquine resistance
3. Type RI resistance to halofantrine in West Africa
4. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum
5. Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models
6. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue
7. Novel metallocenic compounds as antimalarial agents. Study of the position of ferrocene in chloroquine
8. Synthesis and antimalarial activity in vitro of potential metabolites of ferro-chloroquine and related compounds
9. Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents
10. A P-glycoprotein homologue of Plasmodium falciparum is isolated on the digestive vacuole
11. In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites
12. A molecular marker for chloroquine-resistant falciparum malaria
13. In vitro antimalarial activity of a new organometallic analog, ferrocenechloroquine
14. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerization by quinoline antimalarials
15. Folate metabolism in malaria
16. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
17. Antimalarial schizonticides: Ferriprotoporphyrin IX interaction hypothesis
18. Site of action of the antimalarial hydroxynaphthoquinone, 2-(trans-4(4′-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone (566C80)
19. (Tyr) polymorphism in Lamberene, Gabon
20. Synthesis of novel ferrocenyl sugars and their antimalarial activities
21. Quinine resistant falciparum malaria acquired in East Africa
22. Antimalarials increase vesicle pH in Plasmodium falciparum
23. Paludisme à Plasmodium falciparum: Résistance de type RI à la quinine en Afrique de l'Est
24. New targets for antimalarial drug discovery
25. In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine
26. In vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum comparison with standard antimalarial drugs
27. Sensibilité in vitro d'isolats gabonais de Plasmodium falciparum vis-à-vis de la chloroquine et du cycloguanil
28. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine
29. In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs
30. Ferrocene-chloroquine analogues as antimalarial agents: In vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum
31. Failure of antimalarial prophylaxis with mefloquine in Africa
32. Etude de l'acquisition de la prémunition en zones d'holo et mésoendémie palustre à dielmo et à ndiop (Sénégal). Résultats préliminaires, 1990-94
33. The Dielmo project: A longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal
34. Impact of chloroquine resistance on malaria mortality
35. The development and spread of drug-resistant malaria
36. Susceptibility of human malaria parasites to chloroquine is pH dependent